Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid 18 F‐fluorodeoxyglucose‐positron emission tomography and CT perfusion study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid 18 F‐fluorodeoxyglucose‐positron emission tomography and CT perfusion study

Published:2018-10-03 Issue:1 Volume:63 Page:94-101
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:J Med Imaging Radiat Oncol

Author:

Yang Dae‐Myoung¹²³^ORCID,Palma David⁴⁵,Louie Alexander⁴⁵,Malthaner Richard⁶,Fortin Dalilah⁶,Rodrigues George⁴⁵,Yaremko Brian⁴⁵^ORCID,Laba Joanna⁴⁵,Gaede Stewart¹⁴⁷,Warner Andrew⁵,Inculet Richard⁶,Lee Ting‐Yim¹²³

Affiliation:

1. Department of Medical Biophysics Western University London Ontario Canada

2. Robarts Research Institute Western University London Ontario Canada

3. Lawson Health Research Institute London Ontario Canada

4. Department of Oncology Western University London Ontario Canada

5. Department of Radiation Oncology London Regional Cancer Program London Ontario Canada

6. Department of Surgery Division of Thoracic Surgery London Health Sciences Centre London Ontario Canada

7. Department of Engineering and Physics Western University London Ontario Canada

Funder

Ontario Institute for Cancer Research

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1754-9485.12807

Reference29 articles.

1. Cancer statistics, 2018

2. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

3. Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned

4. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma

5. MA 13.07 A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials;Frontiers in Pharmacology;2023-10-24

2. Diagnostic Value of Dynamic 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer;Diagnostics;2023-07-29

3. Diagnostic value of dynamic 18F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes;Quantitative Imaging in Medicine and Surgery;2023-04

4. Simulation of a novel, non‐invasive radiation detector to measure the arterial input function for dynamic positron emission tomography;Medical Physics;2022-11-09

5. Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutes;EJNMMI Research;2021-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3